Human Immunodeficiency Virus HIV Plasma
Human Immunodeficiency Virus HIV Plasma - Cryopreserved human plasma collected from clinically confirmed HIV donors. Human Immunodeficiency Virus HIV plasma is ideal for viral load measurements, monitoring treatment efficacy, and detecting drug resistance mutations. Bulk plasma is available.
| Lot # | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 73460 | HIV | 1.0 ML | Hispanic/Latino | 52 | Male | United States |
biktarvy 50-200-25 MG daily
|
6 | $316.00 | |
| 72469 | HIV | 1.0 ML | Caucasian | 40 | Female | United States |
Biktarvy 25mg QD
|
9 | $316.00 | |
| 71936 | HIV | 1.0 ML | Caucasian | 45 | Male | United States |
Biktarvy 50mg/200mg/25mg QD Wellbutrin 300mg QD Adderall 10mg QD lamictal 10mg QD Biosil 105mg BID Hair Supplement QD
|
9 | $316.00 | |
| 68985 | HIV | 1.0 ML | Hispanic/Latino | 46 | Male | United States |
10mg atorvastatin 1x/day Genvoya 3in1 1x/day Estradiol Valerate 0.2 ml injection 1/week progesterone 2 100mg @ night; 15 days on 15 days off
|
9 | $316.00 | |
| 66246 | HIV | 1.0 ML | Caucasian | 65 | Male | United States |
Biktarvy Statin Tamsulosin Olanzapine
|
8 | $316.00 | |
| 68179 | HIV | 1.0 ML | African American | 45 | Male | United States |
Cabenuva injection q2 months
|
8 | $316.00 | |
| 65954 | HIV | 1.0 ML | Caucasian Asian/Pacific Islander | 44 | Female | United States |
Biktarvy Hydrochlorothiazide
|
9 | $316.00 | |
| 64557 | HIV | 1.0 ML | Hispanic/Latino | 38 | Male | United States |
Biktarvy 50/200/25 mg
|
7 | $316.00 | |
| 64207 | HIV | 1.0 ML | Caucasian | 64 | Male | United States |
Biktarvy
|
9 | $316.00 | |
| 64391 | HIV | 1.0 ML | African American | 36 | Male | United States |
Triumeq / 600-50-300 mg tablet / QD Linzess 145 mcg
|
4 | $316.00 |
HIV Plasma | Human Plasma from HIV-Positive Donors
Human Immunodeficiency Virus (HIV) Plasma is collected from donors clinically diagnosed with HIV and processed within hours of collection to preserve key analytes such as viral RNA, cytokines, proteins, and metabolites. This human plasma supports viral load quantification, drug resistance research, and immune biomarker studies. Bulk apheresis plasma is available for high-volume programmes.
Specify Viral Load and Treatment Status
HIV plasma is not a single product — what the sample contains depends almost entirely on where the donor sits in their treatment course, and this is the most common source of mismatch between what researchers order and what they need:
- Viremic, treatment-naive — detectable to high viral load; the material for viral load assay calibration, sequencing, and drug resistance work
- On ART, virally suppressed — viral load below detection limits. Correct for immune reconstitution and chronic inflammation studies, but unsuitable for anything requiring detectable virus
- Elite controllers and long-term non-progressors — rare donors maintaining suppression without therapy; available as a custom collection
- Acute and early infection — including seroconversion series where collected
- Defined viral load ranges — samples selected to hit a target copies/mL window for assay validation
Donor Stratification Available
- Viral load — HIV-1 RNA copies/mL where tested
- CD4+ T cell count and CD4/CD8 ratio where recorded
- Treatment status — naive, on ART, or treatment-interrupted, with regimen where available
- Subtype/clade where genotyped
- Drug resistance mutations where sequenced
- Co-infections — hepatitis B, hepatitis C, tuberculosis
- Matched seronegative controls available
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed HIV donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
- Bulk apheresis plasma available for large-volume requirements
- Anticoagulant specified to your protocol (EDTA standard for viral load work)
De-identified Donor Data
- Verified HIV diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional HIV-specific metadata available
Applications
- HIV viral load assay development, calibration, and validation
- Drug resistance genotyping and sequencing
- Diagnostic and seroconversion panel preparation
- Chronic immune activation and inflammation research
- Biomarker discovery and validation
- Metabolomics and proteomics studies
- Therapeutic and cure-strategy response research
Other HIV Specimen Types
Matched material from HIV-positive donors is available as HIV whole blood, HIV CD3+ T cells, HIV leukopak, and HIV bulk plasma.
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
HIV plasma is available in standard, custom, and bulk volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations — infectious material shipping requires additional documentation in many jurisdictions. For the full specimen range, see our human plasma collection.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Plasma
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.